Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Citrine Medicine
AddedFeb 17, 2024
UpdatedJun 18, 2026
Citrine Medicine

Citrine Medicine

Citrine Medicine: Innovating therapies for rare diseases in China, enhancing patient lives.

HQ
Cambridge, MA, US
Founded
2019
Overview
Compare
Fundraising
Employees

Citrine Medicine is a therapeutic platform company focused on developing innovative therapies for rare disease patients with unmet medical needs in China. The company is dedicated to improving the lives of patients with rare and intractable diseases by making diagnosis and essential treatments available and accessible.

Citrine Medicine has achieved significant milestones in the rare disease sector, enhancing patient outcomes through its advanced therapeutic solutions. The company's impactful work has garnered attention and support from key stakeholders in the healthcare industry.

Citrine Medicine - Similar Companies

Phoenicis logo

Phoenicis

Star Therapeutics logo

Star Therapeutics

Chroma Medicine logo

Chroma Medicine

Courage Therapeutics logo

Courage Therapeutics

River 3 Renal logo

River 3 Renal

Brii Biosciences logo

Brii Biosciences

briibio.com

Precision Theranostics logo

Precision Theranostics

cystetic Medicines logo

cystetic Medicines

SanaRx Biotherapeutics logo

SanaRx Biotherapeutics

Link Medicine logo

Link Medicine

linksciences.com

Tisento Therapeutics logo

Tisento Therapeutics

Orphan Star Therapeutics logo

Orphan Star Therapeutics

CinRx Pharma logo

CinRx Pharma

cinrx.com

Faze Medicines logo

Faze Medicines

fazemed.com

Orbital Therapeutics logo

Orbital Therapeutics

Citrine Medicine - Quick Facts

Who are Citrine Medicine's competitors?

Companies similar to Citrine Medicine include Phoenicis, Star Therapeutics, Chroma Medicine and Courage Therapeutics.

When was Citrine Medicine founded?

Citrine Medicine was founded in 2019.

Where is Citrine Medicine's headquarters located?

Citrine Medicine's headquarters is located in Cambridge, MA, US.

When was Citrine Medicine's last funding round?

Citrine Medicine's most recent funding round was for $80M (USD) in July 2020.

How much has Citrine Medicine raised to-date?

As of Jul 13, 2020, Citrine Medicine has raised a total of $80M (USD).

How many employees does Citrine Medicine have?

Citrine Medicine has 30 employees as of Feb 4, 2024.

Citrine Medicine - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Model
  • Platform
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Therapeutics
  • Therapies
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 12 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified